|Mr. Jakob O. Sigurdsson BA, MBA||CEO & Exec. Director||1.07M||N/A||1964|
|Mr. Richard J. Armitage F.C.M.A.||Group Fin. Director & Exec. Director||329.96k||N/A||1966|
|Dr. Martin L. Court||Chief Commercial Officer of Industrial & Medical Divisions and Exec. Director||546.8k||N/A||1962|
|Mr. Andrew Hanson||Director of Investor Relations & Corp. Communications||N/A||N/A||N/A|
|Louise Waldek||Gen. Counsel & Company Sec.||N/A||N/A||N/A|
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.
Victrex plc’s ISS Governance QualityScore as of October 4, 2019 is 3. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 1; Compensation: 4.